Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: exemestane (Aromasin®)
Sponsor: Pfizer